- Previous Close
700.65 - Open
688.45 - Bid --
- Ask --
- Day's Range
674.15 - 713.45 - 52 Week Range
440.25 - 937.95 - Volume
27,175 - Avg. Volume
100,305 - Market Cap (intraday)
48.767B - Beta (5Y Monthly) 0.13
- PE Ratio (TTM)
-- - EPS (TTM)
-0.83 - Earnings Date Feb 3, 2025 - Feb 7, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 2, 2022
- 1y Target Est
--
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. Unichem Laboratories Limited was founded in 1944 and is based in Mumbai, India.
www.unichemlabs.com2,875
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: UNICHEMLAB.NS
View MorePerformance Overview: UNICHEMLAB.NS
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UNICHEMLAB.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UNICHEMLAB.NS
View MoreValuation Measures
Market Cap
48.57B
Enterprise Value
49.59B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.83
Price/Book (mrq)
2.03
Enterprise Value/Revenue
2.87
Enterprise Value/EBITDA
36.34
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.50%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
17.28B
Net Income Avi to Common (ttm)
-605.5M
Diluted EPS (ttm)
-0.83
Balance Sheet and Cash Flow
Total Cash (mrq)
1.52B
Total Debt/Equity (mrq)
10.48%
Levered Free Cash Flow (ttm)
--